Designing In Vivo T-Cell Therapies to Combat Resistance & Enhance Durability in Solid Tumors

• Identifying mechanisms of resistance to understand impact in vivo CAR-T durability
• Balancing armored CAR/TCR designs to optimize long-term efficacy while minimizing safety risks
• Evaluating in vivo therapeutic approaches for treating solid tumors in complex tumor microenvironments

Speakers:

Peggy Sotiropoulou

Chief Scientific Officer

T-knife GmbH